Greenphire wins big at the 2024 MedTech Breakthrough Award

The company says its mission is geared towards enhancing clinical research site performance and participant satisfaction.

This prestigious accolade recognizes Greenphire’s outstanding achievements in improving the participant experience through advanced patient-facing solutions. This marks the company’s fifth consecutive win, highlighting its sustained excellence in innovative solutions, client support, and ongoing advancements.

The MedTech Breakthrough Awards received over 4,500 nominations in 2024 from across the globe. These awards honor companies and innovative solutions that address critical needs, solve complex problems, seize opportunities, and create or revolutionize new markets or industries.

Greenphire explained that advanced patient payment technology, mobile engagement application, and market-leading global travel and logistics services were key factors in securing this win.

The company says its streamlined and automated workflow simplifies the participant reimbursement and payments process. This automation reduces the administrative burden on site staff while enhancing participant engagement and retention. With more than 4.5 million clinical trial participants paid and a 91% satisfaction rating across over 70,000 clinical research sites, Greenphire believes it sets the industry standard in automating participant payments, offering unmatched simplicity, security, and global reach.

In April 2023, it launched GreenSpace, a patient-facing mobile and web app that serves as a central hub for key study information and tasks. GreenSpace includes features such as financial views and receipt capture, itinerary details, meaningful insights, feedback surveys, and more. This patient-centric digital platform aims to improve accessibility, diversity, engagement, and retention worldwide by providing global trial participants with a uniform experience.